Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1981 1
1982 3
1983 2
1984 2
1985 2
1986 3
1987 4
1988 8
1989 20
1990 24
1991 49
1992 66
1993 72
1994 95
1995 105
1996 90
1997 83
1998 85
1999 96
2000 93
2001 65
2002 69
2003 57
2004 58
2005 81
2006 71
2007 77
2008 70
2009 59
2010 61
2011 47
2012 62
2013 85
2014 70
2015 95
2016 96
2017 95
2018 100
2019 125
2020 97
2021 117
2022 186
2023 162
2024 177
2025 271
2026 132

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,200 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lipoprotein and atherosclerosis (47,583 results)?
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.
Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S, Goliopoulou A, Kalogeras K, Tsigkou V, Kalpis A, Paschou SA, Theofilis P, Vavuranakis M, Tousoulis D, Siasos G. Lampsas S, et al. Molecules. 2023 Jan 18;28(3):969. doi: 10.3390/molecules28030969. Molecules. 2023. PMID: 36770634 Free PMC article. Review.
Lipoprotein(a) (Lp(a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipoprotein(a). ...This narrative review aims to summarize knowledge regarding the mechanisms mediating the effect of Lp(a) on inflammation, atherosclerosis and th …
Lipoprotein(a) (Lp(a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipoprotein(a). ...This narrat …
Lipoprotein(a): Role in atherosclerosis and new treatment options.
Tomic Naglic D, Manojlovic M, Pejakovic S, Stepanovic K, Prodanovic Simeunovic J. Tomic Naglic D, et al. Biomol Biomed. 2023 Jul 3;23(4):575-583. doi: 10.17305/bb.2023.8992. Biomol Biomed. 2023. PMID: 37183706 Free PMC article. Review.
Atherosclerosis is a chronic process characterized by inflammation and the progressive accumulation of inflammatory cells and lipids in the blood vessel wall, resulting in narrowing of the blood vessel's circumference. ...The results of previous studies indicated that l …
Atherosclerosis is a chronic process characterized by inflammation and the progressive accumulation of inflammatory cells and lipids …
Lipoprotein(a) and cardiovascular disease.
Boffa MB, Koschinsky ML. Boffa MB, et al. Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037. Biochem J. 2024. PMID: 39302109 Free PMC article. Review.
Elevated plasma levels of lipoprotein(a) (Lp(a)) are a prevalent, independent, and causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Lp(a) consists of a lipoprotein particle resembling low density lipoprot …
Elevated plasma levels of lipoprotein(a) (Lp(a)) are a prevalent, independent, and causal risk factor for atherosclerotic card …
Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review.
Duarte Lau F, Giugliano RP. Duarte Lau F, et al. JAMA Cardiol. 2022 Jul 1;7(7):760-769. doi: 10.1001/jamacardio.2022.0987. JAMA Cardiol. 2022. PMID: 35583875 Review.
IMPORTANCE: Lipoprotein(a) (Lp[a]) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipoprotein(a). ...While an absolute risk threshold remains to be universally accepted, an estimated 20% to 25% of the global population have Lp(a) levels of …
IMPORTANCE: Lipoprotein(a) (Lp[a]) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipoprotein(a). .. …
Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.
Ugovšek S, Šebeštjen M. Ugovšek S, et al. Biomolecules. 2021 Dec 24;12(1):26. doi: 10.3390/biom12010026. Biomolecules. 2021. PMID: 35053174 Free PMC article. Review.
Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD and DAS. ...
Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aortic ste …
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults.
Man S, Zu Y, Yang X, Deng Y, Shen D, Ma Y, Fu J, Du J, Yu C, Lv J, Li G, Wang B, Li L. Man S, et al. J Am Coll Cardiol. 2025 Jun 3;85(21):1979-1992. doi: 10.1016/j.jacc.2025.02.032. Epub 2025 Apr 23. J Am Coll Cardiol. 2025. PMID: 40266173 Free article.
BACKGROUND: Elevated lipoprotein(a) [Lp(a)] is strongly associated with an increased risk of atherosclerotic cardiovascular disease; yet, large-scale studies on the epidemiology of elevated Lp(a) as well as its association with subclinical atherosclerosis in …
BACKGROUND: Elevated lipoprotein(a) [Lp(a)] is strongly associated with an increased risk of atherosclerotic cardiovascular di …
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.
Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky ML, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoğlu LS, Catapano AL. Kronenberg F, et al. Atherosclerosis. 2023 Jun;374:107-120. doi: 10.1016/j.atherosclerosis.2023.04.012. Epub 2023 Apr 28. Atherosclerosis. 2023. PMID: 37188555 Free article. Review.
In 2022, the European Atherosclerosis Society (EAS) published a new consensus statement on lipoprotein(a) [Lp(a)], summarizing current knowledge about its causal association with atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. ...
In 2022, the European Atherosclerosis Society (EAS) published a new consensus statement on lipoprotein(a) [Lp(a)], summ …
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Reyes-Soffer G, et al. Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14. Arterioscler Thromb Vasc Biol. 2022. PMID: 34647487 Free PMC article. Review.
High levels of lipoprotein(a) [Lp(a)], an apoB100-containing lipoprotein, are an independent and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis. ...
High levels of lipoprotein(a) [Lp(a)], an apoB100-containing lipoprotein, are an independent and causal risk factor for athero …
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a).
Nissen SE, Ni W, Shen X, Wang Q, Navar AM, Nicholls SJ, Wolski K, Michael L, Haupt A, Krege JH; ALPACA Trial Investigators. Nissen SE, et al. N Engl J Med. 2025 May 1;392(17):1673-1683. doi: 10.1056/NEJMoa2415818. Epub 2025 Mar 30. N Engl J Med. 2025. PMID: 40162643 Clinical Trial.
BACKGROUND: Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. ...CONCLUSIONS: Lepodisiran reduced mean serum concentrations of lipoprotein(a) from 60 to 180 days after administration. (Funded by Eli Lill …
BACKGROUND: Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. ...CONCLUSIONS: …
3,200 results